Related references
Note: Only part of the references are listed.Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells
Mamoru Tanaka et al.
BMC CANCER (2013)
Trefoil factor 1 suppression of E-CADHERIN enhances prostate carcinoma cell invasiveness and metastasis
N. M. Bougen et al.
CANCER LETTERS (2013)
Mesenchymal stem cell-like cells from children foreskin inhibit the growth of SGC-7901 gastric cancer cells
Yahong Li et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2013)
Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144
Idoia G. Zubeldia et al.
EXPERIMENTAL CELL RESEARCH (2013)
Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study
Kensei Yamaguchi et al.
GASTRIC CANCER (2013)
KLF8 involves in TGF-beta-induced EMT and promotes invasion and migration in gastric cancer cells
Hui Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line
Jin Ren et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Oncogenic B-RAFV600E Signaling Induces the T-Box3 Transcriptional Repressor to Repress E-Cadherin and Enhance Melanoma Cell Invasion
Suzanah C. Boyd et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer
Tong Liu et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
SNAI1-Mediated Epithelial-Mesenchymal Transition Confers Chemoresistance and Cellular Plasticity by Regulating Genes Involved in Cell Death and Stem Cell Maintenance
Soyoung Lim et al.
PLOS ONE (2013)
β-catenin Overexpression in the Nucleus Predicts Progress Disease and Unfavourable Survival in Colorectal Cancer: A Meta-Analysis
Zhigang Chen et al.
PLOS ONE (2013)
miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN
Shou-mei Yang et al.
TOXICOLOGY (2013)
The resveratrol analog 4,4′-dihydroxy-trans-stilbene suppresses transformation in normal mouse fibroblasts and inhibits proliferation and invasion of human breast cancer cells
Cristina Maccario et al.
CARCINOGENESIS (2012)
Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer
Shu Shimada et al.
GUT (2012)
Loss of E-cadherin and Acquisition of Vimentin in Epithelial-Mesenchymal Transition are Noble Indicators of Uterine Cervix Cancer Progression
Na-Hye Myong
KOREAN JOURNAL OF PATHOLOGY (2012)
Loss of E-cadherin promotes the growth, invasion and drug resistance of colorectal cancer cells and is associated with liver metastasis
Xiaobing Chen et al.
MOLECULAR BIOLOGY REPORTS (2012)
Clinical implications of N-cadherin expression in gastric cancer
Takahito Kamikihara et al.
PATHOLOGY INTERNATIONAL (2012)
RhoGDI2 confers gastric cancer cells resistance against cisplatin-induced apoptosis by upregulation of Bcl-2 expression
Hee Jun Cho et al.
CANCER LETTERS (2011)
E-Cadherin and the Cytoskeletal Network in Colorectal Cancer Development and Metastasis
Andrea Buda et al.
CELL COMMUNICATION AND ADHESION (2011)
Acquisition of Chemoresistance and EMT Phenotype Is Linked with Activation of the Endothelin A Receptor Pathway in Ovarian Carcinoma Cells
Laura Rosano et al.
CLINICAL CANCER RESEARCH (2011)
A Gene Expression Signature of Acquired Chemoresistance to Cisplatin and Fluorouracil Combination Chemotherapy in Gastric Cancer Patients
Hark Kyun Kim et al.
PLOS ONE (2011)
Loss of Function of E-Cadherin in Embryonic Stem Cells and the Relevance toModels of Tumorigenesis
Lisa Mohamet et al.
JOURNAL OF ONCOLOGY (2011)
Increased expression of p27 is associated with the cisplatin resistance in gastric cancer cell line YCC-3
Tuong Vy Thi Le et al.
ARCHIVES OF PHARMACAL RESEARCH (2010)
Tumor-stromal cell interactions and opportunities for therapeutic intervention
Taturo Udagawa et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
The morphological and molecular features of the epithelial-to-mesenchymal transition
Gema Moreno-Bueno et al.
NATURE PROTOCOLS (2009)
Regulation of in situ to invasive breast carcinoma transition
Min Hu et al.
CANCER CELL (2008)
Activated Androgen Receptor Downregulates E-Cadherin Gene Expression and Promotes Tumor Metastasis
Yan-Nian Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Sustained TGFβ exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis
A. Gal et al.
ONCOGENE (2008)
Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Hector Peinado et al.
NATURE REVIEWS CANCER (2007)
Transforming growth factor-β employs HMGA2 to elicit epithelial-mesenchymal transition
Sylvie Thuault et al.
JOURNAL OF CELL BIOLOGY (2006)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
Gene expression profiling of normal human pulmonary fibroblasts following coculture with non-small-cell lung cancer cells reveals alterations related to matrix degradation, angiogenesis, cell growth and survival
O Fromigué et al.
ONCOGENE (2003)
Transforming growth factor β-1 induces snail transcription factor in epithelial cell lines -: Mechanisms for epithelial mesenchymal transitions
H Peinado et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)